Showing all published months. Partner preview tables include up to 5 countries.
USD value by month, all available partner countries combined
Free partner preview shows up to 5 countries.
Total value across the selected data period
| Partner | Value | Share |
|---|---|---|
| Japan | $169.5K | 100.0% |
Availability is confirmed when the API response loads.
| Partner | Value | Share |
|---|---|---|
| Japan | $77K | 100.0% |
| Year | Export value |
|---|---|
| 2024 | $92.5K |
| 2025 | $77K |
Public data shows up to 5 partner countries for this exact eight-digit customs code. Request all available partner-month rows in CSV.
HS 30036090 is also written 3003.60.90. Values are in USD; the public series does not report tonnes or kg. Product scope: Antimalarial medicaments based on active principles other than artemisinin and its derivatives fall under this heading when supplied in bulk rather than measured doses or retail…. The public page shows monthly export partner previews from official GACC customs statistics. Full partner-month rows are available through a scoped custom data request.
Source: China General Administration of Customs (GACC), cleaned and structured by China Data Portal.
Transformations: Values are presented as published by the source.
China Data Portal. "China Medicaments of other antimalarial active principles, neither in measured doses nor in retail packings (HS 30036090) Export Data." https://chinadata.live/china-trade/hs8/30036090/
China exported $169K of medicaments of other antimalarial active principles, neither in measured doses nor in retail packings in the 2 months to November 2025, averaging $84.7K per month, based on official China customs statistics (HS 30036090).
Antimalarial medicaments based on active principles other than artemisinin and its derivatives fall under this heading when supplied in bulk rather than measured doses or retail…
Figures come from official China General Administration of Customs (GACC) statistics, published monthly. ChinaData cleans partner names, periods and values so the series is ready for analysis. Partner-level rows for every month, including HS8 detail, are available on request.